Bacterial Infections: all 665 studies

Page 7 of 7. Open to participants first (99), then studies with results posted, then the rest; newest registration first within each.

• PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)CompletedNCT00472667Not applicable
• Quinolone Resistance in Bloodstream Isolates of Escherichia ColiCompletedNCT00449735
• Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical WardsCompletedNCT00431483Not applicable
• Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract SurgeryTerminatedNCT00431028Phase 1/2
• Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT RecipientsWithdrawnNCT00430469Phase 1/2
• A Three-Part Study Of GSK580416 In Healthy SubjectsCompletedNCT00427141Phase 1
• Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU PatientsCompletedNCT00410527Phase 4
• Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of InfectionTerminatedNCT00407147Phase 4
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe SepsisCompletedNCT00406198Phase 4
• Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream IsolatesWithdrawnNCT00394784
• Antiseptic Use and Dressing ApplicationCompletedNCT00389558Phase 4
• Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)CompletedNCT00358371Phase 1
• Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy VolunteersCompletedNCT00357539Phase 1
• Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy VolunteersCompletedNCT00357383Phase 1
• Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy VolunteersCompletedNCT00357292Phase 1
• Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy VolunteersCompletedNCT00356850Phase 1
• Azithromycin Level in Tears and in Conjunctiva in 36 Healthy VolunteersCompletedNCT00356772Phase 1
• A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of PhototoxicityCompletedNCT00353158Phase 1
• Therapeutic Zinc in Infant Bacterial IllnessCompletedNCT00347386Phase 2/3
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
• Evaluation of Atuna Racemosa ToxicityCompletedNCT00318344Phase 1
• Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICUTerminatedNCT00307099Phase 3
• Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter ColonizationCompletedNCT00288418Phase 3
• Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant BacteriaCompletedNCT00275327
• Bacterial Pulmonary Infection in PICUCompletedNCT00271531
• Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in NepalCompletedNCT00271440Phase 1/2
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00259909
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258102Phase 3
• Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)CompletedNCT00254696Phase 4
• Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric PatientsTerminatedNCT00240747Phase 3
• Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCompletedNCT00229060Phase 3
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
• Doripenem in the Treatment of Complicated Intra-Abdominal InfectionsCompletedNCT00210938Phase 3
• Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.CompletedNCT00205816Phase 3
• Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.CompletedNCT00200928Not applicable
• Etiology, Prevention and Treatment of Neonatal Infections in the CommunityCompletedNCT00198627Not applicable
• Contrast-Enhanced US of Spleen, Liver and KidneyStatus unknownNCT00190281
• Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young InfantsStatus unknownNCT00189384Phase 3
• Gram Negative Bacteremia, Risk Factors for Failure of TherapyCompletedNCT00177957
• Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care UnitCompletedNCT00177814
• Leukocyte Depletion of Autologous Whole BloodCompletedNCT00176124Phase 4
• Novel Protective UndergloveCompletedNCT00170586Phase 2
• Reducing Vaginal Infections in WomenCompletedNCT00170430Phase 3
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT00167999
• Study Evaluating Vancomycin-Resistant Enterococci in a Hematology UnitCompletedNCT00167960
• Time To Efficacy and Onset Of Action Of LinezolidCompletedNCT00147511Phase 4
• Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard AntibioticsCompletedNCT00136292Phase 1
• Topical SB-275833 Ointment, 1% For The Treatment Of ImpetigoCompletedNCT00133874Phase 3
• Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) TrialCompletedNCT00100386Not applicable
• Unfractioned Heparin for Treatment of SepsisCompletedNCT00100308Phase 3
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsCompletedNCT00081744Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative OrganismsCompletedNCT00079989Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00079976Phase 3
• Daptomycin for the Treatment of Infections Due to Gram-Positive BacteriaTerminatedNCT00055198Phase 3
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionCompletedNCT00044928Phase 4
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)CompletedNCT00035854Phase 3
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)CompletedNCT00035269Phase 3
• Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate VaccinesCompletedNCT00008853Phase 1
• Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic FibrosisCompletedNCT00004829Phase 3
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic FibrosisCompletedNCT00004747Phase 2
• A Study of Azithromycin in HIV-Infected PatientsCompletedNCT00002344Phase 1
• Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.CompletedNCT00002139Phase 1
• Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedNCT00000826Phase 1
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive ChildrenCompletedNCT00000811Phase 2

← Bacterial Infections overview